Deck 7 Webinars and Virtual Events

| January 1, 2020

article image
If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Spotlight

Austriamed - Medical Treatments in Austria

AT-MED offers access to premium medical services in top clinics and hospitals in Austria. Through AT-MED you have full medical testings in half a day, in the same medical unit and a reliable team made up of world-renowned doctors and professors, for whom your needs will come first. In the Austrian medical institutions the patient is assisted throughout the stay by the attending physician. The hospital collaborates for all medical disciplines with the most famous physicians, who are requested according to the specificity of each case, all under the guidance of the AT-MED team. Excellent interdisciplinary collaboration among specialists is of crucial importance for the accuracy of diagnosis and the initiation of optimal therapy for each particular case. Based on the motto "Everything from a single source," the patient receives, with virtually no waiting time, all the medical services they need. Currently, AT-MED is the official partner for top medical clinics and hospitals in Austria: AK

OTHER ARTICLES

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Spotlight

Austriamed - Medical Treatments in Austria

AT-MED offers access to premium medical services in top clinics and hospitals in Austria. Through AT-MED you have full medical testings in half a day, in the same medical unit and a reliable team made up of world-renowned doctors and professors, for whom your needs will come first. In the Austrian medical institutions the patient is assisted throughout the stay by the attending physician. The hospital collaborates for all medical disciplines with the most famous physicians, who are requested according to the specificity of each case, all under the guidance of the AT-MED team. Excellent interdisciplinary collaboration among specialists is of crucial importance for the accuracy of diagnosis and the initiation of optimal therapy for each particular case. Based on the motto "Everything from a single source," the patient receives, with virtually no waiting time, all the medical services they need. Currently, AT-MED is the official partner for top medical clinics and hospitals in Austria: AK

Events